Imperagen

United Kingdom · Biotech · AI · Hardware

Uses quantum physics simulation and AI to engineer high-performance enzymes for pharma and industrial markets

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed£5MEnterprise Cheshire + Warrington — Role not disclosedGMC Life Sciences Fund By PXN Ventures — Role not disclosedGreater Manchester Combined Authority — Role not disclosedIQ Capital — Role not disclosedNorthern Gritstone — Role not disclosedNPIF II - PXN Equity Finance — Role not disclosedPXN Ventures — Role not disclosed
Sourcesimperagen.com ↗